ANGO Financial Facts

Operating income: 3.02M
Cost of sales: 47.25M
See Full Income Statement

Total stockholders' equity: -1.06B
Accounts payable: -47.65M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 10/10/14 *Est. EPS Growth Rate +157.1% *Last Qtr.
Average EPS % Beat Rate +65.3% Revenue Growth Rate +4.6% *Last Qtr.
Average % Move 1-Wk after EPS -2.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M N/A Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A Details
1/3/13 Q213 $0.10$0.09 +$0.01$87M$87.4M = Details
4/9/14 Q314 $0.16$0.09 +$0.07$88.2M$86.85M N/A Details
7/11/13 Q413 $0.07$0.06 +$0.01$90M$86.43M N/A Details
10/8/12 Q113 $0.10$0.09 +$0.01$83.4M$84.35M = Details
10/10/13 Q114 $0.04$0.03 +$0.01$83.6M$82.54M N/A Details
4/8/13 Q313 $0.05$0.05 $0.00$81.6M$81.7M = Details